Skip to Main Content
International Foundation for CDKL5 Research Logo
Donate Now
About
Back
About Us
About CDKL5
Our Team
News & Views
Events
For Families
Back
Resource Library
CDKL5 Centers Of Excellence
Recently Diagnosed
Support Match
Research & Trials
Back
Help Get CDKL5 Clinical Trial Ready!
Research Opportunities
Get Involved
Back
Ways to Get Involved
Fundraising
Advocacy
Photo Release
IFCR Trademark Guidelines
For Investigators
Back
Request for Proposals
Research Toolbox
CDKL5 Variant Tool
CDKL5 Patient-Focused Drug Development
Contact Us
Shop IFCR
facebook
twitter
instagram
linkedin
youtube
search
Donate Now
News & Views
Newsletter Archive
Filter by Year
Filter by Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
Filter
Shop for IFCR
Read More
November 14, 2023
share on facebook
tweet
share on email
UX055 Program Update RE: Delayed IND Filing
Read More
November 3, 2023
share on facebook
tweet
share on email
VIP Sibling
Read More
October 4, 2023
share on facebook
tweet
share on email
CDKL5 Publication Breakdown: specific inhibitor of CDKL5
Read More
August 8, 2023
share on facebook
tweet
share on email
IFCR Invited to Ultragenyx Ribbon-Cutting
Read More
July 11, 2023
share on facebook
tweet
share on email
Harvard Brain Tissue Resource Center (HBTRC) Statement
Read More
June 16, 2023
share on facebook
tweet
share on email
CDKL5 Publication Breakdown: Epileptic Spasms in CDD
Read More
June 13, 2023
share on facebook
tweet
share on email
Jesus Gonzalez Appointed Inaugural Executive Director of IFCR
Read More
January 31, 2023
share on facebook
tweet
share on email
CDKL5 Alliance Membership Update
Read More
October 13, 2022
share on facebook
tweet
share on email
CDKL5 Mom Walks to Remember
Read More
May 16, 2022
share on facebook
tweet
share on email
The Lancet Neurology Publishes Review of Clinical Features, Diagnosis and Management of CDKL5 Deficiency Disorder
Read More
April 25, 2022
share on facebook
tweet
share on email
Sodium channel blockers are not to be dismissed for the treatment of seizures in CDKL5 deficiency disorder
Read More
March 15, 2022
share on facebook
tweet
share on email
Load More